Direct production of antibodies using a synthetic peptide derived from a protein sequence is one of possible strategies to obtain the antibody of interest.
This strategy has the advantage to be less time consuming than classical approach (e.g. cloning, expression and purification of protein…) and produce a very specific peptide antisera.
MilleGen pay particular attention to the choice of a well characterised peptide sequence to obtain antibodies against the protein under investigation.
Close collaboration between bioinformatic department and our experts in the field give all essential informations to peptide synthesis department in order to produce the suitable peptide-antibody.
